The EXPLAIN Study: Exploring Arthrogryposis Multiplex Congenita in Adults in Norway — A Description of Demographic, Medical, and Neurological Findings
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 10.06.2026
DOI: 10.1002/ajmg.c.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 10.06.2026. Verfasst von My Vuong Hermansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Norwegian Centre for Rare Diseases, Unit Sunnaas, Sunnaas Rehabilitational Hospital, Nesodden, Norway. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF).
Abstract (Originalsprache)
Arthrogryposis Multiplex Congenita (AMC) encompasses several hundred conditions with diverse genetic, pathophysiological, and clinical origins. The overarching EXPLAIN study explores underlying causes and implications of AMC and represents the largest clinical cohort of adults with AMC reported to date. This part of the EXPLAIN study aims to describe demographic, medical, and neurological findings in adults with AMC in Norway. A complete social, medical, and surgical history was therefore obtained, and the clinical examination comprised phenotype descriptions, anthropometry, neurological and neurophysiological tests, and blood analyses. Seventy‐two adults (44 women), 18 to 80 years, were included. 57% reported neurological disease or symptoms. Spinal or truncal involvement was observed in 63%, and craniofacial malformations were observed in 36%. Central nervous system involvement frequently manifested as sensory hearing impairment (26%) and ophthalmoplegia (18%). Peripheral features included axial muscle weakness (53%), areflexia (44%), and hypotonia (40%). Neurogenic changes were identified in 61% of electrophysiological studies, with 31% showing sensory‐motor neuropathy. Medical follow‐up was required in 75%. This study highlights significant phenotypic variability in socioeconomic factors, medical comorbidities, and clinical presentation of AMC. The prevalence of musculoskeletal and neurological variations emphasizes the need for multidisciplinary care throughout life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Norwegian Centre for Rare Diseases, Unit Sunnaas, Sunnaas Rehabilitational Hospital, Nesodden, Norway.
- Department of Neurology, Section for Rare Neurological Disorders, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Neurology, Oslo University Hospital, Oslo, Norway.
- Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
ORCID-Profile: My Vuong Hermansen, Kristin Ørstavik, Unni Steen, Mathias Toft, Cathrine Brunborg, Lena Lande Wekre
Förderung
- the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF)
Zitieren
APA
Hermansen, M. V., Ørstavik, K., Steen, U., Toft, M., Brunborg, C., & Wekre, L. L. (2026). The EXPLAIN Study: Exploring Arthrogryposis Multiplex Congenita in Adults in Norway — A Description of Demographic, Medical, and Neurological Findings. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.70017
Vancouver
Hermansen MV, Ørstavik K, Steen U, Toft M, Brunborg C, Wekre LL. The EXPLAIN Study: Exploring Arthrogryposis Multiplex Congenita in Adults in Norway — A Description of Demographic, Medical, and Neurological Findings. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2026. doi:10.1002/ajmg.c.70017
BibTeX
@article{Hermansen2026,
author = {Hermansen, My Vuong and Ørstavik, Kristin and Steen, Unni and Toft, Mathias and Brunborg, Cathrine and Wekre, Lena Lande},
title = {The EXPLAIN Study: Exploring Arthrogryposis Multiplex Congenita in Adults in Norway — A Description of Demographic, Medical, and Neurological Findings},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2026},
doi = {10.1002/ajmg.c.70017}
}
EUVIMED